NO951022L - Fremgangsmåte for isolering av biomolekyler ved ionebytting - Google Patents

Fremgangsmåte for isolering av biomolekyler ved ionebytting

Info

Publication number
NO951022L
NO951022L NO951022A NO951022A NO951022L NO 951022 L NO951022 L NO 951022L NO 951022 A NO951022 A NO 951022A NO 951022 A NO951022 A NO 951022A NO 951022 L NO951022 L NO 951022L
Authority
NO
Norway
Prior art keywords
ion exchange
pct
ion
exchange material
exchanging groups
Prior art date
Application number
NO951022A
Other languages
English (en)
Other versions
NO951022D0 (no
Inventor
Allan Otto Fog Lihme
Margit Irene Aagesen
Cla Gammelgaard-Larsen
Katrine Hvid Ellegaard
Original Assignee
Kem En Tec As
Md Foods Amba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kem En Tec As, Md Foods Amba filed Critical Kem En Tec As
Publication of NO951022D0 publication Critical patent/NO951022D0/no
Publication of NO951022L publication Critical patent/NO951022L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

Det blir beskrevet en fremgangsmåte for Isolering av et biomolekyl fra et medium Inneholdende biomolekyler ved Ionebytting, hvor lonebyttematerlalet omfatter et materiale med lonebyttegrupper som kan bil omdannet til en ladet form til en uladet form; eluerlngsmldlet omfatter en ladnlngsnøytraliserende syre eller base som omformer lonbyttegruppene fra den ladede form til den uladede form; og den ladnlngsnøytrallserende syren eller basen har en konsentrasjon l eluerlngsmldlet som er to ganger fortrinnsvis Ilk eller lavere enn konsentrasjonen av lonebyttegruppene l lonebyttematerl- alet; hvor nevnte lonebyttematerlale er l en pakket, hydrert tilstand. Spesielt blir det beskrevet en slik fremgangsmåte for Isolering av fosfopeptlder fra et medium Inneholdende kaselnhydrolysater. Det blir også beskrevet anvendelse av silke Isolerte biomolekyler for fremstillingen av et mat-, f6r-, helseprodukt, et kosmetlka eller et farmasøytlka.
NO951022A 1992-09-17 1995-03-16 Fremgangsmåte for isolering av biomolekyler ved ionebytting NO951022L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK921143A DK114392D0 (da) 1992-09-17 1992-09-17 Isolering af biomolekyler
PCT/DK1993/000299 WO1994006822A1 (en) 1992-09-17 1993-09-17 Method of isolating biomolecules by ion exchange

Publications (2)

Publication Number Publication Date
NO951022D0 NO951022D0 (no) 1995-03-16
NO951022L true NO951022L (no) 1995-04-06

Family

ID=8101496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951022A NO951022L (no) 1992-09-17 1995-03-16 Fremgangsmåte for isolering av biomolekyler ved ionebytting

Country Status (11)

Country Link
US (1) US5780593A (no)
EP (1) EP0666866B1 (no)
JP (1) JPH08509115A (no)
AT (1) ATE211146T1 (no)
AU (1) AU686568B2 (no)
DE (1) DE69331389D1 (no)
DK (2) DK114392D0 (no)
FI (1) FI951274A0 (no)
NO (1) NO951022L (no)
NZ (1) NZ255996A (no)
WO (1) WO1994006822A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1010300A3 (fr) * 1996-05-22 1998-05-05 Personnalite Juridique De La S Procede de preparation de peptides exempts de phenylalanine.
US6783962B1 (en) * 1999-03-26 2004-08-31 Upfront Chromatography Particulate material for purification of bio-macromolecules
AU2002235795A1 (en) * 2000-12-31 2002-07-16 Amersham Biosciences Ab A method for the manufacture of compositions containing low concentrations of salts
JP3946747B2 (ja) * 2004-02-17 2007-07-18 森永乳業株式会社 ラクトパーオキシダーゼの製造方法
US7157004B1 (en) * 2004-11-29 2007-01-02 Sandia Corporation Freeze drying for gas chromatography stationary phase deposition
US20090074893A1 (en) * 2005-04-29 2009-03-19 Campina Nederland Holding B.V. Antiviral peptides
WO2007092827A2 (en) * 2006-02-08 2007-08-16 Waters Investments Limited Improved separation method
CN101101283A (zh) * 2006-07-05 2008-01-09 中国科学院大连化学物理研究所 一种分离富集磷酸化肽的方法
WO2010068093A1 (en) 2008-12-08 2010-06-17 Campina Nederland Holding B.V. Particulate fat-containing powder, its preparation and its use
AU2010215959A1 (en) 2009-02-20 2011-08-04 Ventria Bioscience Cell culture media containing combinations of proteins
CA2945964C (en) * 2014-04-23 2022-06-14 Liang Chen Egg white processing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
JPS58170440A (ja) * 1982-03-30 1983-10-07 Meiji Seika Kaisha Ltd 健康飲食品
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4957779A (en) * 1988-02-18 1990-09-18 Lanxide Technology Company, Lp Method for producing a protective layer on a ceramic body
US4876398A (en) * 1988-06-10 1989-10-24 China Petrochemical Development Corporation Preparation of ortho-alkylated phenols in the presence of a catalyst prepared by co-precipitation process
EP0476199A1 (en) * 1990-09-21 1992-03-25 Unilever Plc Process to isolate phosphopeptides
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
ES2149771T3 (es) * 1991-04-19 2000-11-16 Univ Melbourne Produccion de fosfopeptidos a partir de la caseina.

Also Published As

Publication number Publication date
NZ255996A (en) 1997-04-24
DK114392D0 (da) 1992-09-17
EP0666866A1 (en) 1995-08-16
AU686568B2 (en) 1998-02-12
DE69331389D1 (de) 2002-01-31
ATE211146T1 (de) 2002-01-15
FI951274A (fi) 1995-03-17
DK0666866T3 (da) 2002-04-15
FI951274A0 (fi) 1995-03-17
JPH08509115A (ja) 1996-10-01
NO951022D0 (no) 1995-03-16
WO1994006822A1 (en) 1994-03-31
EP0666866B1 (en) 2001-12-19
US5780593A (en) 1998-07-14
AU4814893A (en) 1994-04-12

Similar Documents

Publication Publication Date Title
NO951022L (no) Fremgangsmåte for isolering av biomolekyler ved ionebytting
FR2723849B1 (fr) Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
FR2736343B1 (fr) Composition a base d'oxyde de zirconium et d'oxyde de cerium, procede de preparation et utilisation
DE69102707D1 (de) In einem DNA - Gel stabilisierte Heilwasserliposomen.
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
MX9604020A (es) Arilalquildiazinonas.
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
ATE2191T1 (de) Rosmarinsaeure-phospholipid komplexe, verfahren zur ihrer herstellung und sie enthaltende arzneimittel.
IE832529L (en) ß-CARBOLINES, PROCESS FOR THEIR PRODUCTION AND¹PHARMACEUTICAL PREPARATIONS CONTAINING THEM
ZA944303B (en) Nucleic acid sequences vectors containing them pharmaceutical compositions and therapeutic uses
ATA15894A (de) Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
IL59100A (en) Compositions comprising a reaction product between a nicotinic acid derivative and a polyhydroxy compound for use as cosmetics and a process for the preparation of the active ingredients
ES8107307A1 (es) Un procedimiento de preparacion de un vector de transferen- cia de adn
FR2576212B1 (fr) Procede et produit pour maigrir, contenant des huiles essentielles
DE69613984D1 (de) Für die protein-kinase a-spezifische modifizierte oligonukleotide und verfahren zur deren verwendung
ES8502418A1 (es) Un procedimiento para la preparacion de polipeptidos.
HUT47947A (en) Process for producing unsaturated amino acid compounds and pharmaceuticals comprising same as active ingredient
GB1294261A (en) HALOGEN SUBSTITUTED alpha-(AMINOALKYL)-BENZYL ALCOHOLS
ATE68207T1 (de) Verfahren zur thermoinduzierbaren genexpression in grampositiven bakterien, bacillus subtilis staemme, die plasmide enthalten, die eine solche expression induzieren und portable vektorsysteme.
AU541532B2 (en) Purify starting materials in making amphotensides
DE69301186D1 (de) Gleichseitiges Verfahren zur Herstellung von Bildern durch Wärmeübertragung
ATE26577T1 (de) 1-0-alkyl-3-amino-propan-1.2-diol-2-0phospholipide, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
DE3264007D1 (en) 5,6-dihydro-11-alkylene-morphantridin-6-ones, process for their preparation and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application